DOP2002000419A - SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION. - Google Patents

SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION.

Info

Publication number
DOP2002000419A
DOP2002000419A DO2002000419A DO2002000419A DOP2002000419A DO P2002000419 A DOP2002000419 A DO P2002000419A DO 2002000419 A DO2002000419 A DO 2002000419A DO 2002000419 A DO2002000419 A DO 2002000419A DO P2002000419 A DOP2002000419 A DO P2002000419A
Authority
DO
Dominican Republic
Prior art keywords
self
inhibitors
cholesterile
emulsioning
formulations
Prior art date
Application number
DO2002000419A
Other languages
Spanish (es)
Inventor
Michael Ellis Perlman
Michael Jon Gumkowski
Sharad Balasaheb Murdande
Franco LOMBARDO
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to DO2002000419A priority Critical patent/DOP2002000419A/en
Publication of DOP2002000419A publication Critical patent/DOP2002000419A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Inhibidores de CETP que tienen mejor solubilidad y biodisponibilidad en un vehículo lipófilo que comprende un aceite digerible, un disolvente lipófilo o un tensioactivo. Tales composiciones preferidas son autoemulsionantes o automicroemulsionantes y comprenden 1. un inhibidor de CETP; 2. un codisolvente; 3. un tensioactivo que tiene un HLB de 1 a 8; 4. un tensioactivo que tiene un HLB de 8 a 20; y 5. opcionalmente, un aceite digerible.CETP inhibitors that have better solubility and bioavailability in a lipophilic vehicle comprising a digestible oil, a lipophilic solvent or a surfactant. Such preferred compositions are self-emulsifying or self-emulsifying and comprise 1. a CETP inhibitor; 2. a co-solvent; 3. a surfactant having an HLB of 1 to 8; 4. a surfactant having an HLB of 8 to 20; and 5. optionally, a digestible oil.

DO2002000419A 2002-06-18 2002-06-18 SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION. DOP2002000419A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2002000419A DOP2002000419A (en) 2002-06-18 2002-06-18 SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2002000419A DOP2002000419A (en) 2002-06-18 2002-06-18 SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION.

Publications (1)

Publication Number Publication Date
DOP2002000419A true DOP2002000419A (en) 2003-01-15

Family

ID=44261084

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2002000419A DOP2002000419A (en) 2002-06-18 2002-06-18 SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION.

Country Status (1)

Country Link
DO (1) DOP2002000419A (en)

Similar Documents

Publication Publication Date Title
UY27344A1 (en) SELF-EMULSIONING FORMULATIONS
ATE420619T1 (en) OILY FOAMABLE AEROSOL COMPOSITION
ATE340238T1 (en) HAND CLEANING PRODUCTS
ATE398997T1 (en) SELF-NANOEMULSIFIING OILY FORMULATION FOR ADMINISTRATION OF POORLY WATER-SOLUBLE MEDICINAL PRODUCTS
HRP20080235T3 (en) FORMULATION OF VACCINE CONTAINING OIL-IN-WATER EMULSION
ATE365536T1 (en) SOLVENT SYSTEMS FOR PHARMACEUTICAL PRODUCTS
CO5600999A2 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE INHIBITORS OF VALSARTAN AND NEUTRAL ENDOPEPTIDASE
BR0115673B1 (en) edible spreadable emulsion and process for preparing a spreadable edible water-in-oil emulsion
UA94404C2 (en) Novel vaccine formulations
UY26338A1 (en) DISPERSIBLE FORMULATIONS CONTAINING LIPASE INHIBITORS
ES2168271T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS.
PE20020336A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A LIPASE INHIBITOR AND A BILIARY ACID SEQUESTRANT
BR0000126A (en) Adjuvants for use in vaccines
SE0000774D0 (en) New formulation
ATE417090T1 (en) STABILIZATION OF ESTER CONCENTRATES OF POLYUNSATURATED FATTY ACIDS
NO20034139L (en) Solid orally dispersible pharmaceutical formulations
DE60000223D1 (en) O / W emulsion containing fibers and their use in cosmetics
ATE516016T1 (en) SELF-EMULSIFYING FORMULATIONS OF CETP INHIBITORS
NO20031909L (en) Self-emulsifying oral dosage formulations of pyranone protease inhibitors
PE20030230A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A LIPASE INHIBITOR AND A SACROSE FATTY ACID ESTER
MY138172A (en) Pharmaceutical compositions based on azetidine derivatives
PL328916A1 (en) Compositions containing inhibitors of hiv protease, such as vx 478 and water-soluble vitamin e compound such as vitamin e-tpgs
DE60312199D1 (en) STEROLESTER AND FOLIC ACID WATER-IN-OIL EMULSION
WO2002053120A3 (en) Cosmetic and dermatological light protection formulations containing benzotriazole derivatives and surfactant sucrose esters
IT1318401B1 (en) N-DESACETYLTHIOCOLCHYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN.